SCHEMBL217200

SCHEMBL217200

CCCCCCCCC=CCCCCCCCC1=NCCN1CCN

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.35
FAAH O00519 5/20 0.35
TRPV1 Q8NER1 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
SOAT1 P35610 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279136 1.00 MGLL (0.35) MGLLFAAHTRPV1MEN1TP53
SCHEMBL5678960 1.00 MGLL (0.35) MGLLFAAHTRPV1MEN1TP53
SCHEMBL17833441 1.00 MGLL (0.35) MGLLFAAHTRPV1MEN1TP53
SCHEMBL2289775 1.00 MGLL (0.35) MGLLFAAHTRPV1MEN1TP53
SCHEMBL7614182 1.00 MGLL (0.35) MGLLFAAHTRPV1MEN1TP53
SCHEMBL11150951 0.97 FAAH (0.33) MGLLFAAHCYP1A2
SCHEMBL11150946 0.97 FAAH (0.33) MGLLFAAHCYP1A2
SCHEMBL11145323 0.95 FASN (0.33) MGLLFAAHCYP1A2
SCHEMBL11145319 0.95 FASN (0.33) MGLLFAAHCYP1A2
Acetic Acid SCHEMBL9118623 0.93 FAAH (0.39) FAAHMEN1TP53CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570243-B2 Non-tin catalyst for curing alkoxysilyl-containing polymer MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-02-25 US claimed
US-20180072837-A1 NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER MOMENTIVE PERFORMANCE MATERIALS INC. 2018-03-15 US claimed
EP-3362499-B1 SYSTEMS AND METHODS FOR FORMING POLYURETHANES EASTMAN CHEM CO (US) 2021-09-22 EP disclosed
US-10640641-B2 Curable coating compositions of silane functional polymers KING INDUSTRIES (US) 2020-05-05 US disclosed
US-20200062953-A1 CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS KING INDUSTRIES 2020-02-27 US disclosed
US-10570243-B2 Non-tin catalyst for curing alkoxysilyl-containing polymer MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2020-02-25 US disclosed
US-20180237635-A1 CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS KING INDUSTRIES 2018-08-23 US disclosed
US-9976028-B2 Curable coating compositions of silane functional polymers KING INDUSTRIES (US) 2018-05-22 US disclosed
US-20180072837-A1 NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER MOMENTIVE PERFORMANCE MATERIALS INC. 2018-03-15 US disclosed
US-20170101502-A1 SYSTEMS AND METHODS FOR FORMING POLYURETHANES EASTMAN CHEMICAL COMPANY (US) 2017-04-13 US disclosed
EP-2334647-B1 LOW-TOXICITY BIODEGRADABLE CORROSION INHIBITORS CECA SA (FR) 2017-03-22 EP disclosed
WO-2012122098-A1 COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME KING INDUSTRIES, INC. (US) 2012-09-13 WO disclosed
US-20120225982-A1 COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME KING INDUSTRIES, INC. 2012-09-06 US disclosed
US-20120070569-A1 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS KING INDUSTRIES, INC. (US) 2012-03-22 US disclosed
US-8088846-B2 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2012-01-03 US disclosed
US-20110186299-A1 Low-Toxicity Biodegradable Corrosion Inhibitors ARKEMA FRANCE (FR) 2011-08-04 US disclosed
US-7485729-B2 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. (US) 2009-02-03 US disclosed
US-20090011124-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes HSIEH BING 2009-01-08 US disclosed
US-20060247341-A1 Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes KING INDUSTRIES, INC. 2006-11-02 US disclosed
US-20060036007-A1 Organometallic compositions and coating compositions KING INDUSTRIES, INC. (US) 2006-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070569-A1 ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS UROD, AOC1, AOC2 MGLL 3232/4885FAAH 3949/4885TRPV1 4412/4885
US-20110186299-A1 Low-Toxicity Biodegradable Corrosion Inhibitors DDT, IDE, DGKI MGLL 775/4885FAAH 1975/4885TRPV1 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.